(LOGC) Logicbio Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Logicbio Therapeutics | (LOGC) share price targets
Complete technical analysis of Logicbio Therapeutics (LOGC) by charts plus indicators, forecast predictions and share price targets for Logicbio Therapeutics (LOGC)
Logicbio Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-08-15 View latest technical analysis
10 day averaged volume of Logicbio Therapeutics is 393490
| Date | Daily Closing Price | Open | High | Low | Volume |
| 15 Thu Aug 2024 | 5.47 | 5.42 | 5.58 | 5.38 | 0.812 times |
| 14 Wed Aug 2024 | 5.36 | 5.30 | 5.42 | 5.29 | 0.548 times |
| 13 Tue Aug 2024 | 5.34 | 5.35 | 5.41 | 5.26 | 0.607 times |
| 12 Mon Aug 2024 | 5.35 | 5.35 | 5.44 | 5.25 | 0.769 times |
| 09 Fri Aug 2024 | 5.36 | 5.13 | 5.38 | 4.92 | 2.115 times |
| 08 Thu Aug 2024 | 5.39 | 5.29 | 5.43 | 5.23 | 0.841 times |
| 07 Wed Aug 2024 | 5.25 | 5.25 | 5.33 | 5.13 | 0.65 times |
| 06 Tue Aug 2024 | 5.21 | 5.16 | 5.24 | 5.04 | 0.556 times |
| 05 Mon Aug 2024 | 5.11 | 5.00 | 5.20 | 4.98 | 1.378 times |
| 02 Fri Aug 2024 | 5.30 | 5.25 | 5.37 | 5.20 | 0.939 times |
My analysis of stock is bearish for shortterm, and stock might move down till 5.3 or till 5. Use a stoploss of 5.51 and if the stock hits stoploss, then it can shoot up till 5.76
Share price targets for Logicbio Therapeutics (LOGC)
| Target Type | Value |
| Downside Target | 2.05 |
| Downside Target | 4.92 |
| Downside Target | 5.20 |
| Upside Target | 5.58 |
| Upside Target | 5.68 |
| Upside Target | 5.84 |
| Upside Target | 5.85 |
| Upside Target | 5.93 |
| Upside Target | 6.05 |
| Upside Target | 6.07 |
| Upside Target | 6.29 |
Intraday share price targets for Logicbio Therapeutics (LOGC)
| Target Type | Value |
| Downside Intraday Target | 5.29 |
| Downside Intraday Target | 5.1 |
| Upside Intraday Target | 5.62 |
| Upside Intraday Target | 5.76 |
| Downside Intraday Target | 5.43 |
Weekly technical analysis of Logicbio Therapeutics (LOGC)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 15 Thu Aug 2024 | 5.47 | 5.35 | 5.58 | 5.25 | 0.494 times |
| 09 Fri Aug 2024 | 5.36 | 5.00 | 5.43 | 4.92 | 0.936 times |
| 02 Fri Aug 2024 | 5.30 | 5.74 | 5.84 | 5.20 | 2.144 times |
| 26 Fri Jul 2024 | 5.79 | 6.05 | 6.07 | 5.68 | 0.768 times |
| 19 Fri Jul 2024 | 6.00 | 6.04 | 6.29 | 5.93 | 1.579 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Logicbio Therapeutics (LOGC)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 15 Thu Aug 2024 | 5.47 | 5.44 | 5.58 | 4.92 | 0.681 times |
| 31 Wed Jul 2024 | 5.40 | 5.59 | 6.29 | 5.34 | 0.604 times |
| 28 Fri Jun 2024 | 5.71 | 5.38 | 6.05 | 5.31 | 1.706 times |
| 31 Fri May 2024 | 5.46 | 5.00 | 5.85 | 5.00 | 2.655 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Logicbio Therapeutics (LOGC)
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Logicbio Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Logicbio Therapeutics in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Logicbio Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Logicbio Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Logicbio Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 5.31 and Logicbio Therapeutics (LOGC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Logicbio Therapeutics (LOGC) stock. Volume based technical analysis of Logicbio Therapeutics (LOGC) stock is negative.
Logicbio Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Logicbio Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Logicbio Therapeutics in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Logicbio Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Logicbio Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Logicbio Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 5.31 and Logicbio Therapeutics (LOGC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Logicbio Therapeutics (LOGC) stock. Volume based technical analysis of Logicbio Therapeutics (LOGC) stock is negative.
Logicbio Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.